Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Phase I/II trials of human bone marrow-derived clonal mesenchymal stem cells for treatment of adults with moderate-to-severe atopic dermatitis.

< BACK TO ARCHIVE


Papers: 29 Jun 2024 - 5 Jul 2024


2024 Jun 27


J Allergy Clin Immunol


38944393

Phase I/II trials of human bone marrow-derived clonal mesenchymal stem cells for treatment of adults with moderate-to-severe atopic dermatitis.

Authors

Seo HM, Lew BL, Lee YW, Son SW, Park CO, Park YL, Baek JO, Shin MK, Kim DH, Lee DH, Jang YH, Ko HC, Na CH, Seo YJ, Ham DS, Kim DJ, Choi GS

Abstract

Mesenchymal stem cells (MSCs) play important roles in therapeutic applications by regulating immune responses.
Read This Paper